News | October 25, 2024
Mankind Pharma completes acquisition of BSV
Potential to optimize and build on the synergies in commercial operations, distribution, manufacturing, supply chain etc.
Potential to optimize and build on the synergies in commercial operations, distribution, manufacturing, supply chain etc.
Extension of long-term collaboration includes construction of new customer-dedicated bioconjugation capacity in Visp (CH) and commercial antibody supply of a new ADC
Product basket comprises 2,047 medicines and 300 surgical devices covering all major therapeutic groups
Spread over 1.26 lakh sq ft building, the super-specialty eye hospital will perform 30,000 free eye surgeries annually for economically weaker sections
India’s first trial for a novel autologous BCMA directed CAR-T cell therapy in patients with relapsed / refractory multiple myeloma
US$ 800 million senior secured notes, the largest high yield debut USD bond issuance from India in the last 10 years
The special financing terms offered by United Imaging and structured by Medikabazaar to Krsnaa Diagnostics underscore the strategic importance of this alliance
India has taken the lead in recognising NAFLD as a major non-communicable disease
At 24 months, data from the Phase 1 exPDite trial continue to show a favorable safety profile in all 12 participants in the trial’s high and low dose cohorts
She reiterated the nation's commitment to eliminating TB as a public health problem by 2030 and ensuring a healthier future for all
Subscribe To Our Newsletter & Stay Updated
